Cargando…
The potential cost-effectiveness of HPV vaccination among girls in Mongolia
INTRODUCTION: Cervical cancer is a leading cause of cancer among women in Mongolia with an age-standardized incidence rate of 23.5 per 100,000. HPV vaccination has not been introduced nationally and Gavi co-financing support is not available in Mongolia. Extended Gavi pricing for HPV vaccine may be...
Autores principales: | Luvsan, Munkh-Erdene, Vodicka, Elisabeth, Jugder, Uranbolor, Tudev, Undarmaa, Clark, Andy, Groman, Devin, Otgonbayar, Dashpagam, Demberelsuren, Sodbayar, LaMongtagne, D. Scott, Pecenka, Clint |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059071/ https://www.ncbi.nlm.nih.gov/pubmed/35509519 http://dx.doi.org/10.1016/j.jvacx.2022.100161 |
Ejemplares similares
-
Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019) -
Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia
por: Sundaram, Neisha, et al.
Publicado: (2017) -
Incidence of Stomach and Esophageal Cancers in Mongolia: Data from 2009 to 2018
por: Lonjid, Tulgaa, et al.
Publicado: (2020) -
The experience of introducing telepathology in Mongolia
por: Tsedenbal, Batchimeg, et al.
Publicado: (2023) -
Use of a Diagonal Approach to Health System Strengthening and Measles Elimination after a Large Nationwide Outbreak in Mongolia
por: Hagan, José E., et al.
Publicado: (2017)